ロード中...

Differential effects of the NMDA receptor antagonist MK-801 on dopamine receptor D1- and D2-induced abnormal involuntary movements in a preclinical model

Dopamine-replacement therapy with L-DOPA is still the gold standard treatment for Parkinson’s disease. One drawback is the common development of L-DOPA-induced dyskinesia (LID) in patients, which can be as disabling as the disease itself. There is no satisfactory adjunct therapy available. Glutamate...

詳細記述

保存先:
書誌詳細
出版年:Neurosci Lett
主要な著者: Flores, Andrew J., Bartlett, Mitchell J., So, Lisa Y., Laude, Nicholas D., Parent, Kate L., Heien, Michael L., Sherman, Scott J., Falk, Torsten
フォーマット: Artigo
言語:Inglês
出版事項: 2014
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4825183/
https://ncbi.nlm.nih.gov/pubmed/24525249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neulet.2014.02.004
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!